FILTER
LATEST INTERVIEWS
Jason Neal
GLOBAL CO-HEAD OF MINING AND METALS GROUP, BMO CAPITAL MARKETS
Jason Neal of BMO Capital Markets explains how mining financing trends have evolved over the last couple of years and what he expects going forward.
Sherif Andrawes
CHAIRMAN, BDO WA MARCH 22, 2017
A spike in exploration IPOs reflects growing optimism within the industry internationally.
Dario Piola
GENERAL MANAGER, TUBIFLEX
Tubiflex offers innovative fluid circulation products for both the aerospace and automotive industries and has recently been acquired by the Interpump Group.
Bicky Bhangu
DIRECTOR, SINGAPORE, ROLLS-ROYCE
Roll-Royce occupies an important role in Singapore’s aerospace industry, leading the way in advanced manufacturing and promoting R&D.
Romain Trapp
PRESIDENT AND CEO, AIRBUS HELICOPTERS CANADA
Fort Erie in Ontario is an important and expanding hub for Airbus Helicopters and Canada is a top market.
Brian Reilly
MANAGING DIRECTOR, CAMECO
With vast economically recoverable uranium resources yet a newly elected government, the future of uranium mining in WA remains uncertain.
Chris Molloy
SENIOR VICE PRESIDENT, OFFICE OF RESEARCH AND ECONOMIC DEVELOPMENT, RUTGERS UNIVERSITY
Rutgers University is a leading national research university that works alongside its corporate neighbors to foster developments in the health sector.
Debbie Hart
PRESIDENT AND CEO, BIONJ
BioNJ is involved in ensuring that New Jersey retains its leading position as a center of global life sciences by facilitating the industry’s development.
John McConnell
PRESIDENT & CEO, VICTORIA GOLD CORPORATION
Victoria Gold is leading the revival of interest in Yukon and aims to begin production at its Eagle Gold project in 2018.
Reg Howard-Smith
CHIEF EXECUTIVE, THE CHAMBER OF MINERALS AND ENERGY OF WESTERN AUSTRALIA (CME)
The CME takes a stance against the National Party’s mining tax proposal.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
